Physician profile
Peter L Webb
NPI 1922024462
$1,848.34
in general payments reported to CMS, 2019-2025
21 companies · $604 in 2025
The $604 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $119 · 2022: $520 · 2023: $233 · 2024: $371 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,208.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $452.50 | 2022-2025 | Resonate El Icd Vr, Lux-Dx Insertable Cardiac Monitor, Accolade Sr |
| Edwards Lifesciences Corporation | $173.80 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $153.86 | 2022-2023 | Lifevest |
| Novartis Pharmaceuticals Corporation | $144.25 | 2022-2025 | |
| Heartflow, INC. | $131.51 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $122.15 | 2025 | Amvuttra |
| Sanofi-Aventis U.S. LLC | $104.18 | 2021 | |
| Abbott Laboratories | $92.68 | 2022-2024 | Cardiomems |
| E.R. Squibb & Sons, L.L.C. | $73.00 | 2022-2025 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $60.53 | 2024-2025 | Wainua |
| Janssen Pharmaceuticals, INC | $55.67 | 2023-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.33 | 2023-2024 | Jardiance |
| Amgen INC. | $40.75 | 2023-2024 | Repatha |
| Vital Connect, INC | $33.48 | 2025 | Vitalpatch Rtm |
| Medtronic, INC. | $31.69 | 2021-2023 | Mycarelink |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $29.20 | 2025 | Attruby |
| Biotronik INC. | $23.51 | 2022 | |
| Philips North America LLC | $21.24 | 2025 | Extended Holter |
| Esperion Therapeutics, INC. | $21.03 | 2022 | |
| Abiomed | $19.77 | 2024 | Impella |
| Daiichi Sankyo INC. | $15.21 | 2024 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.